November 8, 2023
Richie Manikat
Share
https://pubmed.ncbi.nlm.nih.gov/35688226/
The Enhanced Liver Fibrosis Test is a Superior Blood-Based Predictor of Advanced Fibrosis in NAFLD patients < 65 years with Type II Diabetes
June 24, 2025
Aldafermin for the Management of Compensated MASH Cirrhosis: the ALPINE-4 Trial
February 9, 2024
A Stiff Competition: Comparing the MEFIB Index and FAST Score for the Detection of Fibrosis in MASLD
September 22, 2023
